Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomised Trial of First and Second Line Treatments of Helicobacter Pylori Infection in Slovenia

NCT04359966 is registered in ClinicalTrials.gov with Slovenian Society for Gastroenterology and Hepatology as lead sponsor.

NCT NCT04359966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04359966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomised Trial of First and Second Line Treatments of Helicobacter Pylori Infection in Slovenia
Lead sponsor
Slovenian Society for Gastroenterology and Hepatology
Phase
Not applicable
Overall status
Unknown status
Start date
May 10, 2020
Completion date
September 30, 2023
Enrollment
560 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

eradication treatments, helicobacter pylori infection